Trial0
Sign inMap the options

Clinical trial · NCT04684602 · RECRUITING · PHASE1 / PHASE2

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Sponsor: Thomas Advanced Medical LLC

Request access helpRegistry record ↗

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

Interventions

  • PrimePro™/ PrimeMSK™ · BIOLOGICAL

    Injection via condition specific route of administration.

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* Age 18 and older
* Ability to provide informed consent
* Availability for follow up visits

Exclusion Criteria:

* Active or recent malignancy (within last 2 years)
* Pregnancy or breast-feeding
* Inability to provide informed consent

Sites (1)

  • Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City, California · RECRUITING

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2022-04-29.